| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | - | - | 6.0 | - | - | 6.0 |
| 1 | - | - | - | - | - | - | - | - | - | - | - |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | 90.0 | 1505.0 | 1595.0 |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 345.0 |
| 1 | - |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 1947 |
| 1 | 1638 |
Number of post synapses: 6
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 1.0
Columnar completeness: 0.00
Area completeness: nan
Cell size (columns): 1
Number of post synapses: 1595
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 1.0
Columnar completeness: 0.29
Area completeness: 0.40
Cell size (columns): 255
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
| instance | NT | total connections | connections /#aMe20 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | MeLo1 (R) | ACh | 225 | 225.0 | 9.9% | 9.9% |
| 1 | Li18b (R) | GABA | 144 | 144.0 | 6.3% | 16.2% |
| 2 | Li14 (R) | Glu | 121 | 121.0 | 5.3% | 21.5% |
| 3 | LoVC19 (R) | ACh | 113 | 113.0 | 5.0% | 26.4% |
| 4 | Tm16 (R) | ACh | 112 | 112.0 | 4.9% | 31.4% |
| 5 | MeVP1 (R) | ACh | 103 | 103.0 | 4.5% | 35.9% |
| 6 | MeTu4c (R) | ACh | 96 | 96.0 | 4.2% | 40.1% |
| 7 | Tm37 (R) | Glu | 90 | 90.0 | 3.9% | 44.0% |
| 8 | aMe22 (R) | Glu | 89 | 89.0 | 3.9% | 47.9% |
| 9 | aMe4 (R) | ACh | 72 | 72.0 | 3.2% | 51.1% |
| 10 | MeVP11 (R) | ACh | 71 | 71.0 | 3.1% | 54.2% |
| 11 | LoVP5 (R) | ACh | 66 | 66.0 | 2.9% | 57.1% |
| 12 | LC34 (R) | ACh | 60 | 60.0 | 2.6% | 59.7% |
| 13 | aMe1 (R) | GABA | 59 | 59.0 | 2.6% | 62.3% |
| 14 | LC27 (R) | ACh | 56 | 56.0 | 2.5% | 64.8% |
| 15 | MeVC20 (R) | Glu | 56 | 56.0 | 2.5% | 67.2% |
| 16 | LoVC3 (L) | GABA | 50 | 50.0 | 2.2% | 69.4% |
| 17 | Li39 (L) | GABA | 47 | 47.0 | 2.1% | 71.5% |
| 18 | LoVP62 (R) | ACh | 40 | 40.0 | 1.8% | 73.2% |
| 19 | TmY10 (R) | ACh | 38 | 38.0 | 1.7% | 74.9% |
| 20 | LoVP6 (R) | ACh | 37 | 37.0 | 1.6% | 76.5% |
| 21 | aMe3 (R) | Glu | 30 | 30.0 | 1.3% | 77.9% |
| 22 | MeVPMe4 (L) | Glu | 29 | 29.0 | 1.3% | 79.1% |
| 23 | LC20a (R) | ACh | 26 | 26.0 | 1.1% | 80.3% |
| 24 | TmY5a (R) | Glu | 26 | 26.0 | 1.1% | 81.4% |
| 25 | LC37 (R) | Glu | 25 | 25.0 | 1.1% | 82.5% |
| 26 | aMe30 (R) | Glu | 22 | 22.0 | 1.0% | 83.5% |
| 27 | Tm34 (R) | Glu | 19 | 19.0 | 0.8% | 84.3% |
| 28 | MeVP29 (R) | ACh | 16 | 16.0 | 0.7% | 85.0% |
| 29 | aMe5 (R) | ACh | 13 | 13.0 | 0.6% | 85.6% |
| 30 | TmY20 (R) | ACh | 13 | 13.0 | 0.6% | 86.1% |
| 31 | LPC2 (R) | ACh | 12 | 12.0 | 0.5% | 86.7% |
| 32 | aMe10 (L) | ACh | 10 | 10.0 | 0.4% | 87.1% |
| 33 | LoVP36 (R) | Glu | 10 | 10.0 | 0.4% | 87.5% |
| 34 | Cm20 (R) | GABA | 9 | 9.0 | 0.4% | 87.9% |
| 35 | LoVCLo2 (R) | unclear | 9 | 9.0 | 0.4% | 88.3% |
| 36 | LoVP45 (R) | Glu | 9 | 9.0 | 0.4% | 88.7% |
| 37 | Tm38 (R) | ACh | 9 | 9.0 | 0.4% | 89.1% |
| 38 | LoVC20 (L) | GABA | 8 | 8.0 | 0.4% | 89.5% |
| 39 | LoVP12 (R) | unclear | 8 | 8.0 | 0.4% | 89.8% |
| 40 | MeVPMe12 (L) | ACh | 8 | 8.0 | 0.4% | 90.2% |
| 41 | 5-HTPMPV01 (L) | unclear | 7 | 7.0 | 0.3% | 90.5% |
| 42 | LoVC10 (L) | GABA | 7 | 7.0 | 0.3% | 90.8% |
| 43 | TmY17 (R) | ACh | 7 | 7.0 | 0.3% | 91.1% |
| 44 | aMe8 (R) | ACh | 6 | 6.0 | 0.3% | 91.4% |
| 45 | LoVP28 (R) | unclear | 6 | 6.0 | 0.3% | 91.6% |
| 46 | MeVC23 (R) | Glu | 6 | 6.0 | 0.3% | 91.9% |
| 47 | LoVC22 (L) | Dop | 5 | 5.0 | 0.2% | 92.1% |
| 48 | LoVCLo3 (R) | OA | 5 | 5.0 | 0.2% | 92.3% |
| 49 | LoVP46 (R) | Glu | 5 | 5.0 | 0.2% | 92.5% |
| 50 | MeLo5 (R) | ACh | 5 | 5.0 | 0.2% | 92.8% |
| 51 | MeTu4f (R) | ACh | 5 | 5.0 | 0.2% | 93.0% |
| 52 | MeVC24 (R) | Glu | 5 | 5.0 | 0.2% | 93.2% |
| 53 | MeVPMe11 (L) | Glu | 5 | 5.0 | 0.2% | 93.4% |
| 54 | aMe25 (R) | unclear | 4 | 4.0 | 0.2% | 93.6% |
| 55 | Li18a (R) | GABA | 4 | 4.0 | 0.2% | 93.8% |
| 56 | LoVCLo3 (L) | OA | 4 | 4.0 | 0.2% | 93.9% |
| 57 | LoVP67 (R) | unclear | 4 | 4.0 | 0.2% | 94.1% |
| 58 | LoVP79 (R) | unclear | 4 | 4.0 | 0.2% | 94.3% |
| 59 | MeLo7 (R) | ACh | 4 | 4.0 | 0.2% | 94.5% |
| 60 | MeVP38 (R) | ACh | 4 | 4.0 | 0.2% | 94.6% |
| 61 | MeVPMe3 (L) | Glu | 4 | 4.0 | 0.2% | 94.8% |
| 62 | OA-AL2i4 (R) | OA | 4 | 4.0 | 0.2% | 95.0% |
| 63 | LC10c-1 (R) | ACh | 3 | 3.0 | 0.1% | 95.1% |
| 64 | LC36 (R) | ACh | 3 | 3.0 | 0.1% | 95.3% |
| 65 | Li22 (R) | Glu | 3 | 3.0 | 0.1% | 95.4% |
| 66 | LOLP1 (R) | GABA | 3 | 3.0 | 0.1% | 95.5% |
| 67 | LoVCLo2 (L) | unclear | 3 | 3.0 | 0.1% | 95.7% |
| 68 | LoVP103 (R) | ACh | 3 | 3.0 | 0.1% | 95.8% |
| 69 | LoVP14 (R) | ACh | 3 | 3.0 | 0.1% | 95.9% |
| 70 | LoVP16 (R) | ACh | 3 | 3.0 | 0.1% | 96.1% |
| 71 | LoVP37 (R) | unclear | 3 | 3.0 | 0.1% | 96.2% |
| 72 | LoVP38 (R) | Glu | 3 | 3.0 | 0.1% | 96.3% |
| 73 | LT55 (L) | Glu | 3 | 3.0 | 0.1% | 96.4% |
| 74 | LT63 (R) | ACh | 3 | 3.0 | 0.1% | 96.6% |
| 75 | MeVP63 (R) | GABA | 3 | 3.0 | 0.1% | 96.7% |
| 76 | PLP211 (R) | unclear | 3 | 3.0 | 0.1% | 96.8% |
| 77 | Y3 (R) | ACh | 3 | 3.0 | 0.1% | 97.0% |
| 78 | 5thsLNv_LNd6 (R) | ACh | 2 | 2.0 | 0.1% | 97.1% |
| 79 | aMe6a (R) | ACh | 2 | 2.0 | 0.1% | 97.1% |
| 80 | DNpe053 (R) | ACh | 2 | 2.0 | 0.1% | 97.2% |
| 81 | DNpe053 (L) | ACh | 2 | 2.0 | 0.1% | 97.3% |
| 82 | LC14a-2 (L) | ACh | 2 | 2.0 | 0.1% | 97.4% |
| 83 | LC14a-2 (R) | ACh | 2 | 2.0 | 0.1% | 97.5% |
| 84 | LC14b (L) | ACh | 2 | 2.0 | 0.1% | 97.6% |
| 85 | LoVC18 (R) | Dop | 2 | 2.0 | 0.1% | 97.7% |
| 86 | LoVC23 (L) | GABA | 2 | 2.0 | 0.1% | 97.8% |
| 87 | LoVP76 (R) | unclear | 2 | 2.0 | 0.1% | 97.9% |
| 88 | LoVP83 (R) | unclear | 2 | 2.0 | 0.1% | 97.9% |
| 89 | LoVP87 (R) | ACh | 2 | 2.0 | 0.1% | 98.0% |
| 90 | MeLo6 (R) | ACh | 2 | 2.0 | 0.1% | 98.1% |
| 91 | MeTu1 (R) | ACh | 2 | 2.0 | 0.1% | 98.2% |
| 92 | MeVP14 (R) | ACh | 2 | 2.0 | 0.1% | 98.3% |
| 93 | MeVP62 (R) | ACh | 2 | 2.0 | 0.1% | 98.4% |
| 94 | MeVP7 (R) | ACh | 2 | 2.0 | 0.1% | 98.5% |
| 95 | 5-HTPMPV03 (R) | 5HT | 1 | 1.0 | 0.0% | 98.5% |
| 96 | aMe10 (R) | ACh | 1 | 1.0 | 0.0% | 98.6% |
| 97 | aMe2 (R) | Glu | 1 | 1.0 | 0.0% | 98.6% |
| 98 | aMe6b (R) | ACh | 1 | 1.0 | 0.0% | 98.6% |
| 99 | CL125 (R) | unclear | 1 | 1.0 | 0.0% | 98.7% |
| 100 | Cm28 (R) | unclear | 1 | 1.0 | 0.0% | 98.7% |
| 101 | Cm33 (R) | GABA | 1 | 1.0 | 0.0% | 98.8% |
| 102 | DNp27 (L) | unclear | 1 | 1.0 | 0.0% | 98.8% |
| 103 | LC10e (R) | ACh | 1 | 1.0 | 0.0% | 98.9% |
| 104 | LC14a-1 (L) | ACh | 1 | 1.0 | 0.0% | 98.9% |
| 105 | LC22 (R) | ACh | 1 | 1.0 | 0.0% | 98.9% |
| 106 | LC33 (R) | Glu | 1 | 1.0 | 0.0% | 99.0% |
| 107 | LC41 (R) | ACh | 1 | 1.0 | 0.0% | 99.0% |
| 108 | Li13 (R) | GABA | 1 | 1.0 | 0.0% | 99.1% |
| 109 | Li21 (R) | ACh | 1 | 1.0 | 0.0% | 99.1% |
| 110 | LoVC8 (R) | GABA | 1 | 1.0 | 0.0% | 99.2% |
| 111 | LoVP13 (R) | Glu | 1 | 1.0 | 0.0% | 99.2% |
| 112 | LoVP50 (R) | ACh | 1 | 1.0 | 0.0% | 99.3% |
| 113 | LoVP64 (R) | unclear | 1 | 1.0 | 0.0% | 99.3% |
| 114 | LoVP71 (R) | ACh | 1 | 1.0 | 0.0% | 99.3% |
| 115 | LoVP72 (R) | ACh | 1 | 1.0 | 0.0% | 99.4% |
| 116 | LoVP96 (R) | Glu | 1 | 1.0 | 0.0% | 99.4% |
| 117 | LoVP97 (R) | unclear | 1 | 1.0 | 0.0% | 99.5% |
| 118 | LT54 (L) | Glu | 1 | 1.0 | 0.0% | 99.5% |
| 119 | LT58 (R) | Glu | 1 | 1.0 | 0.0% | 99.6% |
| 120 | MeTu4_unclear (R) | ACh | 1 | 1.0 | 0.0% | 99.6% |
| 121 | MeTu4b (R) | ACh | 1 | 1.0 | 0.0% | 99.6% |
| 122 | MeVC21 (R) | Glu | 1 | 1.0 | 0.0% | 99.7% |
| 123 | MeVC22 (R) | Glu | 1 | 1.0 | 0.0% | 99.7% |
| 124 | MeVPLo1 (R) | Glu | 1 | 1.0 | 0.0% | 99.8% |
| 125 | MeVPMe7 (L) | Glu | 1 | 1.0 | 0.0% | 99.8% |
| 126 | OA-ASM1 (R) | OA | 1 | 1.0 | 0.0% | 99.9% |
| 127 | OLVC4 (L) | unclear | 1 | 1.0 | 0.0% | 99.9% |
| 128 | Tm5c (R) | Glu | 1 | 1.0 | 0.0% | 100.0% |
| 129 | TmY13 (R) | ACh | 1 | 1.0 | 0.0% | 100.0% |
| instance | NT | total connections | connections /#aMe20 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | MeVPMe4 (L) | Glu | 2 | 2.0 | 18.2% | 18.2% |
| 1 | aMe22 (R) | Glu | 1 | 1.0 | 9.1% | 27.3% |
| 2 | aMe30 (R) | Glu | 1 | 1.0 | 9.1% | 36.4% |
| 3 | Li39 (L) | GABA | 1 | 1.0 | 9.1% | 45.5% |
| 4 | LoVP38 (R) | Glu | 1 | 1.0 | 9.1% | 54.5% |
| 5 | LoVP41 (R) | ACh | 1 | 1.0 | 9.1% | 63.6% |
| 6 | LoVP54 (R) | ACh | 1 | 1.0 | 9.1% | 72.7% |
| 7 | LoVP81 (R) | unclear | 1 | 1.0 | 9.1% | 81.8% |
| 8 | LT85b (R) | unclear | 1 | 1.0 | 9.1% | 90.9% |
| 9 | MeVC20 (R) | Glu | 1 | 1.0 | 9.1% | 100.0% |